Cosmos Health (COSM) Form 8-K on September 2025 results

Cosmos Health Inc. (COSM) filed a Form 8-K stating that on November 17, 2025 it issued a press release announcing its financial results for the quarter and nine months ended September 30, 2025.

Rhea-AI Filing Summary

Cosmos Health Inc. (COSM) filed a Form 8-K stating that on November 17, 2025 it issued a press release announcing its financial results for the quarter and nine months ended September 30, 2025. The press release is included as Exhibit 99.1 and provides the detailed financial figures and commentary. The company notes that the information in Items 2.02 and 7.01 and in Exhibit 99.1 is being furnished, not filed, under securities law, which limits certain legal liabilities and how the information may be incorporated into other filings.

Insights

Equity research analyst

Routine 8-K furnishing an earnings press release; no figures provided here.

Cosmos Health has furnished a Form 8-K to notify the market that it released financial results for the quarter and nine months ended September 30, 2025. The substantive numbers and narrative are contained in the attached press release labeled Exhibit 99.1, rather than in the body of the report.

The company explicitly treats Items 2.02 and 7.01, and Exhibit 99.1, as information that is "furnished" rather than "filed" under the Exchange Act. This is a common approach for earnings releases and generally reduces potential liability under certain provisions because the information is not automatically incorporated into other registration statements unless specifically referenced.

From an investor perspective, the key details will be in the press release itself, including revenue, profitability and cash metrics for the stated period. Subsequent periodic reports for the same period are likely to provide fuller context and audited or reviewed numbers consistent with standard reporting cycles.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cosmos Health (COSM) announce in its latest Form 8-K?

Cosmos Health filed a Form 8-K stating that on November 17, 2025 it issued a press release with financial results for the quarter and nine months ended September 30, 2025.

Which reporting period does Cosmos Health (COSM)'s 8-K earnings release cover?

The earnings press release furnished with the 8-K covers Cosmos Health's quarter and nine months ended September 30, 2025.

Where can investors find the detailed financial results for Cosmos Health (COSM)?

Detailed figures are contained in Exhibit 99.1 to the Form 8-K, which is the press release issued by Cosmos Health on November 17, 2025.

Is Cosmos Health (COSM)'s earnings information considered filed or furnished?

The company states that the information in Items 2.02 and 7.01 and Exhibit 99.1 is furnished, not filed, under the Securities Exchange Act of 1934.

Which exhibits are included with Cosmos Health (COSM)'s November 17, 2025 Form 8-K?

The Form 8-K includes Exhibit 99.1 (the press release dated November 17, 2025) and Exhibit 104 (the Cover Page Interactive Data File).

Who signed Cosmos Health (COSM)'s November 17, 2025 Form 8-K?

The Form 8-K was signed on behalf of Cosmos Health Inc. by Georgios Terzis, Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 04:30 PM Learn about SEC filing dates

0001474167false00014741672025-11-172025-11-17iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 17, 2025

Cosmos Health Inc.

(Exact name of registrant as specified in its charter)

Nevada		000-54436		27-0611758
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

5 AGIOU GEORGIOU, Pilea, Thessaloniki, Greece		55438
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (312) 865-0026

(Former name or former address, if changed since last report.)

Title of Each Class		Trading Symbol		Name of Each Exchange On Which Registered
Common Stock, $.001 par value		COSM		The Nasdaq Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On November 17, 2025, Cosmos Health Inc., a Nevada corporation (the “Company”), issued a press release announcing its financial results for the quarter and nine months ended September 30, 2025. A copy of the Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference in this Item 2.02.

ITEM 7.01 REGULATION FD DISCLOSURE.

The information set forth in Item 2.02 of this Current Report on Form 8-K is incorporated by reference in this Item 7.01.

In accordance with General Instruction B.2 to Form 8-K, the information set forth in the Items 2.02 and 7.01 and in Exhibit 99.1 hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in that filing.

By furnishing this Current Report on Form 8-K, the Company makes no admission as to the materiality of any information in this Current Report on Form 8-K, including the statements made in Items 2.02 and 7.01 above and in Exhibit 99.1 hereto.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

Exhibit No.		Description
99.1		Press Release issued by Cosmos Health Inc., dated November 17, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	COSMOS HEALTH INC.
Date: November 17, 2025	By:	/s/ Georgios Terzis
		Georgios Terzis
		Chief Financial Officer

3